News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BIOTECHNOLOGY VALUE FUND L P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/30/2023 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 35.8% stake in MoonLake Immunotherapeutics |
| 11/10/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/23/2022 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8.6% stake in Kymera Therapeutics, Inc. |
| 08/11/2022 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 20% stake in CTI BioPharma Corp. |
| 06/01/2022 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8% stake in Kymera Therapeutics, Inc. |
| 01/31/2022 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 7% stake in Kymera Therapeutics, Inc. |
| 01/11/2022 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 18.8% stake in Rain Therapeutics Inc. |
| 12/02/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 18.4% stake in Olema Pharmaceuticals, Inc. |
| 09/15/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 15.7% stake in Rain Therapeutics Inc. |
| 07/06/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 13.6% stake in Rain Therapeutics Inc. |
| 05/25/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10.7% stake in Rain Therapeutics Inc. |
| 04/02/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 31.4% stake in XOMA Corporation |
| 03/15/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 20% stake in CTI BioPharma Corp. |
| 02/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/29/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 20.4% stake in ERYTECH Pharma S.A. |
| 01/26/2021 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 16.7% stake in Infinity Pharmaceuticals, Inc. |
| 01/12/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/15/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 37.9% stake in XOMA Corporation |
| 11/13/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 3.3% stake in Five Prime Therapeutics, Inc. |
| 11/12/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 27.1% stake in Infinity Pharmaceuticals, Inc. |
| 10/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/09/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 38% stake in XOMA Corporation |
| 10/08/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 22.8% stake in Five Prime Therapeutics, Inc. |
| 09/23/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 38% stake in XOMA Corporation |
| 04/17/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 36.6% stake in XOMA Corporation |
| 03/17/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 36.4% stake in XOMA Corporation |
| 03/04/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 20% stake in CTI BioPharma Corp. |
| 02/13/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 35.4% stake in XOMA Corporation |
| 02/04/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 20% stake in CTI BioPharma Corp. |
| 01/10/2020 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 30.6% stake in Infinity Pharmaceuticals, Inc. |
| 12/20/2019 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 27.1% stake in XOMA Corporation |
| 04/26/2019 |
SC 13D/A
| BIOTECHNOLOGY VALUE FUND L P reports a 0% stake in OncoMed Pharmaceuticals, Inc. |
|
|
|